OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
October 09, 2009
GlaxoSmithKline (GSK), Novartis, sanofi aventis and Baxter International have provided updates regarding the development, manufacture and shipment of pandemic (H1NI) vaccines.
A recent analysis by the life-science practice of Capgemini provides insight in how current economic conditions are reshaping the model for supply-chain practices, outsourcing, and other areas of the value chain.
The FDA has issued an alert to healthcare professionals of a change in heparin manufacturing that is expected to decrease the drug?s potency.
Thomas LaVake, manager, worldwide environment, health & safety at Johnson & Johnson, provides a perspective on sustainability practices for the pharmaceutical industry.
October 08, 2009
The US Food and Drug Administration issued an alert to healthcare professionals of a change in heparin manufacturing that is expected to decrease the drug's potency.
The 2009 Nobel Prize in Physiology or Medicine was awarded to three US researchers for the discovery of how chromosomes are protected from degradation by telomeres and the enzyme telomerase during cell division.